Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion evidence source_evidence_literature NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion SIO_000772 21720365 NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion wasDerivedFrom befree-20150227 NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion wasGeneratedBy ECO_0000203 NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
- befree-20150227 importedOn "2015-02-27" NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.